ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DPH Dechra Pharmaceuticals Plc

3,866.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3,866.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dechra Pharmaceuticals PLC Director/PDMR Shareholding (2354K)

19/09/2016 3:10pm

UK Regulatory


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 2354K

Dechra Pharmaceuticals PLC

19 September 2016

The announcement below replaces an announcement released in error on 15 September 2016 under RNS number 9802J. That announcement should have been released on 19 September 2016 in relation to the grant of awards on 19 September 2016 and not 14 September 2016. In addition, the number of awards for Ian Page have been amended from 73,667 to 73,260 as below.

19 September 2016

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

The Company announces that on 19 September 2016 the following Directors were granted awards over ordinary shares of 1 pence each in the Company in connection with the Dechra Long Term Incentive Plan 2008 (the Plan):

 
 Name of individual    Director    Type of award     Number of 
                                                      shares subject 
                                                      to award 
--------------------  ----------  ----------------  ---------------- 
                                   LTIP Award 
                                    - nil cost 
 Ian Page              Director     option                    73,260 
--------------------  ----------  ----------------  ---------------- 
                                   LTIP Award 
                                    - Conditional 
 Tony Griffin          Director     award                     20,858 
--------------------  ----------  ----------------  ---------------- 
 

The vesting of all the above awards is subject to the achievement of performance targets. In respect of these grants the performance conditions will be determined by reference to the Company's Earnings per Share (EPS) and its Total Shareholder Return (TSR) relative to constituent companies of the FTSE 250 index (excluding investment trusts) over a three year performance period. Both the EPS and TSR elements will be subject to an additional Return on Capital Employed (ROCE) performance measure. If the ROCE performance condition is not met, then the LTIP options will lapse in full.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ------------------------------------------------------------------ 
 a)   Name                           Ian Page 
---  -----------------------------  ----------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------ 
 a)   Position/status                Director 
---  -----------------------------  ----------------------------------- 
 b)   Initial notification/          Amendment 
       amendment                      Previous notification reference 
                                      number: 3684. 
                                      The notification should have 
                                      been released on 19 September 
                                      2016 in relation to the grant 
                                      of awards on 19 September 
                                      2016 and not 14 September 
                                      2016. In addition, the number 
                                      of awards have been amended 
                                      from 73,667 to 73,260 as below. 
---  -----------------------------  ----------------------------------- 
 3.   Details of the Issuer 
---  ------------------------------------------------------------------ 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ----------------------------------- 
 b)   LEI code                       N/A 
---  -----------------------------  ----------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------ 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument                     ISIN: GB0009633180 
       Identification 
       code 
---  -----------------------------  ----------------------------------- 
 b)   Nature of                      Grant of nil cost options 
       the transaction                under the Company's Long Term 
                                      Incentive Plan 
---  -----------------------------  ----------------------------------- 
 c)   Price(s) and                   Price(s)           Volume(s) 
       volumes(s) 
                                      Nil cost           73,260 
---  -----------------------------  -----------------  ---------------- 
 d)        Aggregated                 N/A 
            information 
             *    Aggregate volume 
 
 
             *    Price 
---  -----------------------------  ----------------------------------- 
 e)   Date of the                    2016.09.19 
       transaction 
---  -----------------------------  ----------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ----------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ------------------------------------------------------------------ 
 a)   Name                           Tony Griffin 
---  -----------------------------  ----------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------ 
 a)   Position/status                Director 
---  -----------------------------  ----------------------------------- 
 b)   Initial notification/          Amendment 
       amendment                      Previous notification reference 
                                      number: 3687. 
                                      The notification should have 
                                      been released on 19 September 
                                      2016 in relation to the grant 
                                      of awards on 19 September 
                                      2016 and not 14 September 
                                      2016. 
---  -----------------------------  ----------------------------------- 
 3.   Details of the Issuer 
---  ------------------------------------------------------------------ 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ----------------------------------- 
 b)   LEI code                       N/A 
---  -----------------------------  ----------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------ 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument                     ISIN: GB009633180 
       Identification 
       code 
---  -----------------------------  ----------------------------------- 
 b)   Nature of                      Grant of a conditional award 
       the transaction                under the Company's Long Term 
                                      Incentive Plan 
---  -----------------------------  ----------------------------------- 
 c)   Price(s) and                   Price(s)           Volume(s) 
       volumes(s) 
                                      Nil cost           20,858 
---  -----------------------------  -----------------  ---------------- 
 d)        Aggregated                 N/A 
            information 
             *    Aggregate volume 
 
 
             *    Price 
---  -----------------------------  ----------------------------------- 
 e)   Date of the                    2016.09.19 
       transaction 
---  -----------------------------  ----------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ----------------------------------- 
 

For further information, please contact:

Suzana Cross, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHAKCDKQBKDFCD

(END) Dow Jones Newswires

September 19, 2016 10:10 ET (14:10 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock